18-427
Showing 1 - 25 of >10,000
Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Worldwide (AMG 427)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- AMG 427
-
Duarte, California
- +15 more
Jun 16, 2022
Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)
Completed
- Bladder Cancer
- Urothelial Carcinoma
-
Birmingham, Alabama
- +34 more
Jul 7, 2022
Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Leukemia (SLL)
- Zanubrutinib
- +2 more
-
Evanston, Illinois
- +7 more
Sep 9, 2022
Sars-cov-2 on Donor Oocyte Quality and Quantity,Multicenter
Completed
- Ovarian Reserve
- +2 more
- Sars Cov 2 infection
- Sars Cov 2 vaccination
-
Bogotá, ColombiaNovafem
Oct 3, 2022
Obesity, Childhood Trial (Monthly bolus of cholecalciferol per os, Daily dose of cholecalciferol per os, Control)
Not yet recruiting
- Obesity, Childhood
- Monthly bolus of cholecalciferol per os
- +2 more
- (no location specified)
Nov 16, 2022
Eosinophilic Asthma Trial in Worldwide (Reslizumab, Placebo)
Gastric Cancer, Healthy Trial in Hangzhou (No intervention)
Recruiting
- Gastric Cancer
- Healthy
- No intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023
Knee Osteoarthritis Trial in United States (CNTX-4975-05, Lidocaine without epinephrine, ElastoGel)
Pleural Thickening Trial in Sohag (biopsy under sonographic gidance)
Recruiting
- Pleural Thickening
- biopsy under sonographic gidance
-
Sohag, EgyptSohag University Hospital
Jan 26, 2023
MIRACLE of LIFE Study
Active, not recruiting
- Preterm Labor
- +9 more
- Mirvie Predictive Test for Adverse Pregnancy Outcomes
-
San Diego, California
- +9 more
Oct 3, 2023
Migraine, Headache, Photophobia Trial (Avulux Lenses, Placebo Lenses)
Not yet recruiting
- Migraine
- +2 more
- Avulux Lenses
- Placebo Lenses
- (no location specified)
Nov 27, 2023
Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)
Completed
- Asthma
- Benralizumab (Medi-563)
- Placebo
-
Birmingham, Alabama
- +212 more
Oct 20, 2021
Chikungunya Virus Infection Trial in United States (VLA1553, Placebo)
Completed
- Chikungunya Virus Infection
- VLA1553
- Placebo
-
Chandler, Arizona
- +43 more
Jul 25, 2022
Organ Failure, Multiple Trial (FTIR results)
Not yet recruiting
- Organ Failure, Multiple
- FTIR results
- (no location specified)
May 22, 2023
Rectal Cancer Trial (NCRT with surgery, or NCT with surgery, or surgery)
Not yet recruiting
- Rectal Cancer
- NCRT with surgery, or NCT with surgery, or surgery
- (no location specified)
Jan 3, 2023
B-cell Non Hodgkin's Lymphoma Trial in Beijing (HLX01, Rituximab, CHOP)
Completed
- B-cell Non Hodgkin's Lymphoma
- HLX01
- +2 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- BEA 2180 BR
- +2 more
-
Jasper, Alabama
- +177 more
Jul 30, 2021
Obesity Trial in Turku (Weight vest, Wheelchair)
Enrolling by invitation
- Obesity
- Weight vest
- Wheelchair
-
Turku, FinlandTurku University Hospital, Turku PET Centre
Nov 1, 2022
Chronic Low-back Pain, Chronic Pain, Fibromyalgia Trial in Chapel Hill (Green Light stimulation, Equal Energy White stimulation,
Not yet recruiting
- Chronic Low-back Pain
- +2 more
- Green Light stimulation
- +2 more
-
Chapel Hill, North CarolinaUniversity Of North Carolina
Jul 13, 2023
Acute Coronary Syndrome, Depressive Symptoms Trial in United States (Cognitive Behavioral Therapy (CBT), Antidepressant
Completed
- Acute Coronary Syndrome
- Depressive Symptoms
- Cognitive Behavioral Therapy (CBT)
- +4 more
-
Bloomington, Minnesota
- +3 more
Nov 10, 2021
Iodine for 3-6 Years Old Pre-school Children
Recruiting
- Nutritional Requirements
- no intervention
-
Yuncheng, Shandong, ChinaShandong Institute for Endemic Disease Control and Research
Oct 5, 2023